Panion & BF Biotech Inc
TWSE:1760
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
56
89.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Panion & BF Biotech Inc
Operating Income
Panion & BF Biotech Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Panion & BF Biotech Inc
TWSE:1760
|
Operating Income
NT$205.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Operating Income
NT$1.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Operating Income
NT$165.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Operating Income
NT$5.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
31%
|
CAGR 10-Years
101%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Operating Income
NT$1.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Operating Income
-NT$717m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Panion & BF Biotech Inc
Glance View
Panion & BF Biotech, Inc. engages in the manufacturing and sales of medicines, cosmetics, and formula foods. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-06-14. The firm is also involved in the manufacture and sales of various kinds of cosmetics. The firm's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The firm also provides biotechnology services. The firm distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.
See Also
What is Panion & BF Biotech Inc's Operating Income?
Operating Income
205.3m
TWD
Based on the financial report for Dec 31, 2024, Panion & BF Biotech Inc's Operating Income amounts to 205.3m TWD.
What is Panion & BF Biotech Inc's Operating Income growth rate?
Operating Income CAGR 10Y
12%
Over the last year, the Operating Income growth was 31%. The average annual Operating Income growth rates for Panion & BF Biotech Inc have been 7% over the past three years , -2% over the past five years , and 12% over the past ten years .